Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Firazyr
Firazyr
FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
Endpoints
Fri, 06/23/17 - 09:48 am
FDA
CSL
HAE
hereditary angiodema
Shire
Haegarda
Firazyr
Kalbito
How Does Shire Lead the Angioedema Space?
Yahoo/Market Realist
Wed, 04/27/16 - 09:08 am
Shire
Cinryza
Firazyr
HAE
hereditary angiodema
Shire Enters a Crowded Market
Motley Fool
Thu, 09/1/11 - 11:37 am
Shire
Firazyr
Dyax
angioedema
CSL
Shire wins FDA approval for rare disease drug
Bizjournals.com
Thu, 08/25/11 - 01:29 pm
FDA
hereditary angiodema
Shire
Firazyr
Shire's Firazyr effective for hereditary angiodema, FDA says
Pharma Times, UK
Wed, 06/22/11 - 08:18 am
Shire
Firazyr
FDA
hereditary angiodema
Shire advances rival to Dyax drug
Bizjournals.com
Mon, 03/21/11 - 11:34 am
Shire
Dyax
hereditary angiodema
Kalbitor
Firazyr
Label Update for Shire Drug
Yahoo/Zacks
Sat, 03/5/11 - 12:28 pm
Firazyr
hereditary angiodema